Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats - PubMed

Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats

Angela M Sgaravatti et al. Neurochem Int. 2007 Feb.

Abstract

GHB is a naturally occurring compound in the central nervous system (CNS) whose tissue concentration are highly increased during drug abuse and in the inherited deficiency of succinic semialdehyde dehydrogenase (SSADH) activity. SSADH deficiency is a neurometabolic-inherited disorder of the degradation pathway of gamma-aminobutyric acid (GABA). It is biochemically characterized by increased concentrations of gamma-hydroxybutyric acid (GHB) in tissues, cerebrospinal fluid (CSF), blood and urine of affected patients. Clinical manifestations are variable, ranging from mild retardation of mental, motor, and language development to more severe neurological symptoms, such as hypotonia, ataxia and seizures, whose underlying mechanisms are practically unknown. In the present study, the in vitro and in vivo effects of GHB was investigated on some parameters of oxidative stress, such as chemiluminescence, thiobarbituric acid-reactive substances (TBA-RS), total radical-trapping antioxidant potential (TRAP), total antioxidant reactivity (TAR), as well as the activities of the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX) in homogenates from cerebral cortex of 15-day-old Wistar rats. In vitro, GHB significantly increased chemiluminescence and TBA-RS levels, while TRAP and TAR measurements were markedly diminished. In contrast, the activities of the antioxidant enzymes SOD, CAT and GPX were not altered by GHB in vitro. Acute administration of GHB provoked a significant enhance of TBA-RS levels and a decrease of TRAP and TAR measurements. These results indicate that GHB induces oxidative stress by stimulating lipid peroxidation and decreasing the non-enzymatic antioxidant defenses in cerebral cortex of young rats. If these effects also occur in humans, it is possible that they might contribute to the brain damage found in SSADH-deficient patients and possibly in individuals who consume GHB or its prodrug gamma-butyrolactone.

Similar articles

• Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

  Sgaravatti AM, Magnusson AS, Oliveira AS, Mescka CP, Zanin F, Sgarbi MB, Pederzolli CD, Wyse AT, Wannmacher CM, Wajner M, Dutra-Filho CS. Sgaravatti AM, et al. Metab Brain Dis. 2009 Jun;24(2):271-82. doi: 10.1007/s11011-009-9136-7. Epub 2009 Mar 19. Metab Brain Dis. 2009. PMID: 19296210

• The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.

  Deon M, Wajner M, Sirtori LR, Fitarelli D, Coelho DM, Sitta A, Barschak AG, Ferreira GC, Haeser A, Giugliani R, Vargas CR. Deon M, et al. J Neurol Sci. 2006 Sep 25;247(2):157-64. doi: 10.1016/j.jns.2006.04.004. Epub 2006 Jun 5. J Neurol Sci. 2006. PMID: 16750542 Clinical Trial.

• Promotion of oxidative stress by L-tryptophan in cerebral cortex of rats.

  Feksa LR, Latini A, Rech VC, Wajner M, Dutra-Filho CS, de Souza Wyse AT, Wannmacher CM. Feksa LR, et al. Neurochem Int. 2006 Jul;49(1):87-93. doi: 10.1016/j.neuint.2006.01.001. Epub 2006 Feb 23. Neurochem Int. 2006. PMID: 16497412

• Murine succinate semialdehyde dehydrogenase deficiency.

  Gupta M, Hogema BM, Grompe M, Bottiglieri TG, Concas A, Biggio G, Sogliano C, Rigamonti AE, Pearl PL, Snead OC 3rd, Jakobs C, Gibson KM. Gupta M, et al. Ann Neurol. 2003;54 Suppl 6:S81-90. doi: 10.1002/ana.10625. Ann Neurol. 2003. PMID: 12891658 Review.

• Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.

  Gropman A. Gropman A. Ann Neurol. 2003;54 Suppl 6:S66-72. doi: 10.1002/ana.10626. Ann Neurol. 2003. PMID: 12891656 Review.

Cited by

• Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice.

  Latini A, Scussiato K, Leipnitz G, Gibson KM, Wajner M. Latini A, et al. J Inherit Metab Dis. 2007 Oct;30(5):800-10. doi: 10.1007/s10545-007-0599-6. Epub 2007 Sep 21. J Inherit Metab Dis. 2007. PMID: 17885820

• Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies.

  Parviz M, Vogel K, Gibson KM, Pearl PL. Parviz M, et al. J Pediatr Epilepsy. 2014 Nov 25;3(4):217-227. doi: 10.3233/PEP-14097. J Pediatr Epilepsy. 2014. PMID: 25485164 Free PMC article.

• Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

  Kim KJ, Pearl PL, Jensen K, Snead OC, Malaspina P, Jakobs C, Gibson KM. Kim KJ, et al. Antioxid Redox Signal. 2011 Aug 1;15(3):691-718. doi: 10.1089/ars.2010.3470. Epub 2011 Apr 10. Antioxid Redox Signal. 2011. PMID: 20973619 Free PMC article. Review.

• A proposed preventive role for Gamma-hydroxybutyrate (Xyrem(R)) in Alzheimer's disease.

  Maitre M, Klein C, Mensah-Nyagan AG. Maitre M, et al. Alzheimers Res Ther. 2016 Sep 6;8(1):37. doi: 10.1186/s13195-016-0205-y. Alzheimers Res Ther. 2016. PMID: 27601032 Free PMC article. Review.

• Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.

  van Nieuwenhuijzen PS, Long LE, Hunt GE, Arnold JC, McGregor IS. van Nieuwenhuijzen PS, et al. Psychopharmacology (Berl). 2010 Dec;212(4):663-74. doi: 10.1007/s00213-010-1986-5. Epub 2010 Aug 21. Psychopharmacology (Berl). 2010. PMID: 20730418

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Miscellaneous

  • NCI CPTAC Assay Portal